Skip to main content
Top
Published in: Indian Journal of Gastroenterology 1/2011

01-02-2011 | Short Report

Protective role of lipoic acid on methotrexate induced intestinal damage in rabbit model

Authors: Mohammad Hossein Somi, Babak Hajipour, Ghader Dargahi Abbas Abad, Mohammad Reza Hemmati, Kamyar Ghabili, Ali Khodadadi, Amir Mansour Vatankhah

Published in: Indian Journal of Gastroenterology | Issue 1/2011

Login to get access

Abstract

Methotrexate (MTX), a folate antagonist agent, is mainly used in treatment of malignant tumors and auto immune diseases and affects not only tumor cells, but also gastrointestinal mucosa. The present study was undertaken to determine whether lipoic acid (LA) could ameliorate methotrexate-induced oxidative intestine injury in rabbits. Twenty-one rabbits were randomly assigned into three groups: Group 1 (control group), Group 2 (received 20 mg/kg MTX), Group 3 (received MTX plus LA 75 mg/kg orally). On the 6th day rabbits were anesthetized and intestinal tissue sampled for pathologic and biochemical assessment. The intestinal tissue injury index and malondialdehyde (MDA) levels were lower in MTX+LA group as compared to the MTX group, and tissue glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity were higher in MTX+LA group than in the MTX group (p < 0.05). These findings suggest that co-administration of LA with MTX is associated with reduction in oxidative injury and tissue damage in the intestine. We suggest that lipoic acid may have a protective role in the MTX-induced oxidative injury.
Literature
1.
go back to reference Sukhotnik I, Mogilner JG, Karry R, et al. Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in rats. Digestion. 2009;79:5–13.PubMedCrossRef Sukhotnik I, Mogilner JG, Karry R, et al. Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in rats. Digestion. 2009;79:5–13.PubMedCrossRef
2.
go back to reference Mueller-Koch Y, Vogelsang H, Kopp R, et al. HNPCC—clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut. 2005;54:1676–8.CrossRef Mueller-Koch Y, Vogelsang H, Kopp R, et al. HNPCC—clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut. 2005;54:1676–8.CrossRef
3.
go back to reference Gao F, Horie T. A synthetic analog of prostaglandin E1 prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate treated rats. Life Sci. 2002;71:1091–9.PubMedCrossRef Gao F, Horie T. A synthetic analog of prostaglandin E1 prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate treated rats. Life Sci. 2002;71:1091–9.PubMedCrossRef
4.
5.
go back to reference Bilska A, Wlodek L. Lipoic acid—the drug of the future? Pharmacol Rep. 2005;57:570–7.PubMed Bilska A, Wlodek L. Lipoic acid—the drug of the future? Pharmacol Rep. 2005;57:570–7.PubMed
6.
go back to reference Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69.PubMed Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69.PubMed
7.
go back to reference Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8.PubMedCrossRef Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8.PubMedCrossRef
8.
go back to reference Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.PubMed Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.PubMed
9.
go back to reference Ciralik H, Bulbuloglu E, Cetinkaya A, Kurutas EB, Celik M, Polat A. Effects of N-acetylcysteine on methotrexate-induced small intestinal damage in rats. Mt Sinai J Med. 2006;73:1086–92.PubMed Ciralik H, Bulbuloglu E, Cetinkaya A, Kurutas EB, Celik M, Polat A. Effects of N-acetylcysteine on methotrexate-induced small intestinal damage in rats. Mt Sinai J Med. 2006;73:1086–92.PubMed
10.
go back to reference Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi AP. Effects of N-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res. 2000;47:537–48.PubMedCrossRef Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi AP. Effects of N-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res. 2000;47:537–48.PubMedCrossRef
11.
go back to reference Devasagayam TP, Subramanian M, Pradhan DS, Sies H. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem Biol Interact. 1993;86:79–92.PubMedCrossRef Devasagayam TP, Subramanian M, Pradhan DS, Sies H. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem Biol Interact. 1993;86:79–92.PubMedCrossRef
12.
go back to reference Li T, Ito K, Sumi S, Fuwa T, Horie T. Protective effect of aged garlic extract (AGE) on the apoptosis of intestinal epithelial cells caused by methotrexate. Cancer Chemother Pharmacol. 2009;63:873–80.PubMedCrossRef Li T, Ito K, Sumi S, Fuwa T, Horie T. Protective effect of aged garlic extract (AGE) on the apoptosis of intestinal epithelial cells caused by methotrexate. Cancer Chemother Pharmacol. 2009;63:873–80.PubMedCrossRef
Metadata
Title
Protective role of lipoic acid on methotrexate induced intestinal damage in rabbit model
Authors
Mohammad Hossein Somi
Babak Hajipour
Ghader Dargahi Abbas Abad
Mohammad Reza Hemmati
Kamyar Ghabili
Ali Khodadadi
Amir Mansour Vatankhah
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 1/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0090-z

Other articles of this Issue 1/2011

Indian Journal of Gastroenterology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.